Biotechnology (2) | Marketing Agreements (2)
- COVID Joint Development, Manufacturing and Marketing Agreement between NantKwest, Inc. and ImmunityBio, Inc., dated August 21, 2020 (NantKwest, Inc., Filed With SEC on November 9, 2020)
- Amended and Restated Exclusive IP Marketing Agreement, dated as of June 28, 2004, by and between Microment AG and Enzon Pharmaceuticals, Inc (ENZON PHARMACEUTICALS, INC., Filed With SEC on February 21, 2019)
